Aquestive Therapeutics, Inc. short interest in 2024
In 2024, Aquestive Therapeutics, Inc.'s disclosed short interest ran from 2.84% of shares outstanding on 12 Jan 2024 to 11.50% on 31 Dec 2024, a change of +8.66 percentage points. The year's high was 14.72% on 31 Jul 2024 and its low 2.60% on 31 Jan 2024, averaging 8.82% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 10.97 days on 15 Oct 2024. Full history: Aquestive Therapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 2.84% (12 Jan 2024)
- End of year
- 11.50% (31 Dec 2024)
- Change
- +8.66 pp
- High
- 14.72% (31 Jul 2024)
- Low
- 2.60% (31 Jan 2024)
- Average
- 8.82%
- Highest days to cover
- 10.97 (15 Oct 2024)
- SEC filings marked
- 8
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 2.84% | 1.83 | |
| 31 Jan 2024 | 2.60% | 2.98 | |
| 15 Feb 2024 | 2.98% | 3.12 | |
| 29 Feb 2024 | 2.71% | 1.00 | |
| 15 Mar 2024 | 3.16% | 1.00 | 10-K filed, results (8-K) |
| 28 Mar 2024 | 3.10% | 1.00 | |
| 15 Apr 2024 | 5.47% | 1.70 | |
| 30 Apr 2024 | 7.19% | 1.70 | |
| 15 May 2024 | 8.44% | 3.73 | 10-Q filed, results (8-K) |
| 31 May 2024 | 9.14% | 6.53 | |
| 14 Jun 2024 | 9.80% | 7.83 | |
| 28 Jun 2024 | 10.41% | 2.57 | |
| 15 Jul 2024 | 14.15% | 9.45 | |
| 31 Jul 2024 | 14.72% | 7.07 | |
| 15 Aug 2024 | 11.85% | 7.42 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 11.87% | 10.08 | |
| 13 Sep 2024 | 11.86% | 10.26 | |
| 30 Sep 2024 | 12.15% | 7.33 | |
| 15 Oct 2024 | 11.85% | 10.97 | |
| 31 Oct 2024 | 11.14% | 7.29 | |
| 15 Nov 2024 | 10.93% | 5.32 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 11.13% | 8.08 | |
| 13 Dec 2024 | 10.59% | 5.69 | |
| 31 Dec 2024 | 11.50% | 6.99 |
See also: Aquestive Therapeutics, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.